Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Better Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Better Therapeutics Inc market cap is $543,500.00.
What is the 52-week high for Better Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Better Therapeutics Inc 52 week high is $1.35 as of September 24, 2025.
What is the 52-week low for Better Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Better Therapeutics Inc 52 week low is $0.005 as of September 24, 2025.
What is Better Therapeutics Inc stock price today?
Better Therapeutics Inc stock price today is $0.012.
What was Better Therapeutics Inc stock price yesterday?
Better Therapeutics Inc stock price yesterday was $0.01.
What is the PE ratio of Better Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Better Therapeutics Inc’s P/E ratio is -0.01.
What is the Price-to-Book ratio of Better Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Better Therapeutics Inc P/B ratio is -0.0408.
What is Better Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Better Therapeutics Inc's EBITDA is -0.82.
What is the 50-day moving average of Better Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Better Therapeutics Inc 50-day moving average is $0.0776.
